Buy Credit Analysis & Research; target of Rs 1750: ICICI Direct

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

ICICI Direct's research report on Credit Analysis & Research

CARE, the second largest rating company by market share, is a pure play on the rating business with 99% (Rs 281 crore) of its FY17 core revenue generated from the rating segment. The highlight of CARE’s business is its best-in-class EBITDA margin of 60%+ and PAT margin of 50%.

Outlook

We remain structurally positive on the rating business. We revise our target price higher to Rs 1750 (earlier Rs 1650) as we roll over to FY19E, valuing at 25x FY19E EPS & maintain BUY.

For all recommendations, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More